U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746687) titled 'A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma' on July 31.
Brief Summary: The purpose of this study is to assess how well JNJ-95597528 works when compared to placebo in adult participants with moderate to severe asthma (long-term condition that affects the airways in your lungs).
Study Start Date: Sept. 23
Study Type: INTERVENTIONAL
Condition:
Asthma
Intervention:
DRUG: JNJ-95597528
JNJ-95597528 will be administered as subcutaneous (SC) injection.
DRUG: Placebo
Placebo will be administered as SC injection.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Janssen Research & De...